Daniel Nowak

14PUBLICATIONS
117CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 18, 2026
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.

|Jan 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Aug 21, 2025
The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS.

Nanni Schmitt, Jana-Julia Siegler, Alexandra Beck

|Dec 09, 2024
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes.

Jacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike

|May 28, 2024
Cell-type-specific consequences of mosaic structural variants in hematopoietic stem and progenitor cells.

Karen Grimes, Hyobin Jeong, Amanda Amoah

|Oct 06, 2023
Distinct and targetable role of calcium-sensing receptor in leukaemia.

Raquel S Pereira, Rahul Kumar, Alessia Cais

Pageof 3

Frequent Collaborators

4 joint publications

Johann-Christoph Jann

3 joint publications

Wei-Yu Lin

3 joint publications

Jude Fitzgibbon

3 joint publications

Theresa Hahn